Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion type Assertion NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_head.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion description "[Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion evidence source_evidence_literature NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion SIO_000772 22197930 NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion wasDerivedFrom befree-2016 NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.
- NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_assertion wasGeneratedBy ECO_0000203 NP949138.RAc7V_XFGmAc6rhInAx5ApkZqBdpew6MAYY_5iwjAycKA130_provenance.